{"schema_version":"1","generated_at":"2026-11-03T00:18:46.167Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rajat-thawani","json_url":"https://www.findmykol.com/kol/rajat-thawani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rajat-thawani","name":"Rajat Thawani","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Oregon Health & Science University","institution_url":"https://www.findmykol.com/institution/oregon-health-science-university","city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1386176394","orcid":"0000-0002-5378-9434","openalex":"A5026698119"},"summary":"Rajat Thawani is an Oncology physician affiliated with Oregon Health & Science University. OpenAlex indexes 135 publications with 2,575 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":135,"cited_by_count":2575,"h_index":23,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07405086","title":"Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study","phase":"PHASE4","status":"RECRUITING","role":"Overall official","sponsor":"OHSU Knight Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT07405086","trial_url":"https://www.findmykol.com/trial/NCT07405086"}],"source":"trials"},"payments":{"company_count":14,"program_years":{"first":2021,"last":null},"rows_total":16,"shown":3,"withheld":13,"rows":[{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":2077.5,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386176394"},{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2025,"amount_usd":1480,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386176394"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":400.53,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386176394"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1386176394","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":61.1,"classes_total":2,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":38.9,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":11},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":22.2,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":38.9,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":38.9,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives","year":2025,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers17050801","status":"verified"},{"title":"First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study","year":2025,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(25)00409-7","status":"verified"},{"title":"Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-24-02355","status":"verified"},{"title":"Current perspectives of KRAS in non-small cell lung cancer","year":2024,"journal":"Current Problems in Cancer","source_url":"https://doi.org/10.1016/j.currproblcancer.2024.101106","status":"verified"},{"title":"TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers","year":2024,"journal":"npj Precision Oncology","source_url":"https://doi.org/10.1038/s41698-024-00663-1","status":"verified"}],"source":"works"},"contact":{"address_1":"3303 S BOND AVE","city":"Portland","state":"OR","zip":"972394501","phone":"503-494-6594","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1386176394","source":"identity"},"similar":[{"name":"Brian Druker","slug":"brian-druker","institution":"Oregon Health & Science University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brian-druker","json_url":"https://www.findmykol.com/kol/brian-druker/profile.json"},{"name":"Kevin Winthrop","slug":"kevin-winthrop","institution":"Oregon Health & Science University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/kevin-winthrop","json_url":"https://www.findmykol.com/kol/kevin-winthrop/profile.json"},{"name":"Richard Maziarz","slug":"richard-maziarz","institution":"Oregon Health & Science University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/richard-maziarz","json_url":"https://www.findmykol.com/kol/richard-maziarz/profile.json"},{"name":"Wayne Clark","slug":"wayne-clark","institution":"Oregon Health & Science University","specialty":"Neurology","url":"https://www.findmykol.com/kol/wayne-clark","json_url":"https://www.findmykol.com/kol/wayne-clark/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":13,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-02-11","provider_certified":"2025-02-11","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}